Evidence map›Paper›PMID 34976852›Full record

ReviewFrontiers in cellular and infection microbiology2021

Audrey Gueniche, Muriel Liboutet, Stephanie Cheilian, Dominique Fagot, Franck Juchaux, Lionel Breton

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Pharmaceutics · 2026
    Article
  4. Review
  5. Review
  6. Postbiotics: an insightful review of the latest category in functional biotics.World journal of microbiology & biotechnology · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Skin Deep: The Potential of Microbiome Cosmetics.Journal of microbiology (Seoul, Korea) · 2024
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Audrey GuenicheL'Oreal Research and Innovation, Luxury Division Dept, Chevilly-La-Rue, France.
Muriel LiboutetL'Oreal Research and Innovation, Luxury Division Dept, Chevilly-La-Rue, France.
Stephanie CheilianL'Oreal Research and Innovation, Luxury Division Dept, Chevilly-La-Rue, France.
Dominique FagotL'Oreal Research and Innovation, Advanced Research Dept, Aulnay-sous-Bois, France.
Franck JuchauxL'Oreal Research and Innovation, Advanced Research Dept, Aulnay-sous-Bois, France.
Lionel BretonL'Oreal Research and Innovation, Advanced Research Dept, Aulnay-sous-Bois, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The term probiotic has been defined by experts as live microorganisms, which when administered in adequate amounts, confer a health benefit on the host. Probiotics are, thus, by definition, live microorganisms, and the viability of probiotics is a prerequisite for certain benefits, such as the release of metabolites at the site or adhesion properties, for example. However, some semi-active or non-replicative bacterial preparations may retain a similar activity to the live forms. On cosmetic, lysates or fractions are generally used. Topically applied

Indexed as

ProbioticsVitreoscillaPlant ExtractsSkin CarePlant Extractsimmunitymicrobiomeskin barrierskin defencesVitreoscilla

Identifiers

PMID34976852
PMCPMC8717924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.